Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard H Drew

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Medical Mycology|March 4, 2011
Overview of treatment options for invasive fungal infectionsMelanie W Pound, Mary L Townsend, Vincent Dimondi, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 2017
Impact of automatic infectious diseases consultation on the management of fungemia at a large academic medical centerTravis M Jones, Richard H Drew, Dustin T Wilson, et al.
Infection Control and Hospital Epidemiology|March 16, 2012
Constructing unit-specific empiric treatment guidelines for catheter-related and primary bacteremia by determining the likelihood of inadequate therapyMegan E Davis, Deverick J Anderson, Michelle Sharpe, et al.
Clinical Therapeutics|May 31, 2015
Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor AgonistsStephanie L Payk, Richard H Drew, Jennifer D Smith, et al.
Cancer Medicine|March 20, 2014
Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort studyHsiang-Chi Kung, Melissa D Johnson, Richard H Drew, et al.
Expert Opinion on Pharmacotherapy|September 21, 2013
Recent advances in the treatment of life-threatening, invasive fungal infectionsRichard H Drew, Mary L Townsend, Melanie W Pound, et al.
Therapeutics and Clinical Risk Management|August 19, 2016
Role of isavuconazole in the treatment of invasive fungal infectionsDustin T Wilson, V Paul Dimondi, Steven W Johnson, et al.
Transplantation|January 27, 2004
Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipientsRichard H Drew, Elizabeth Dodds Ashley, Daniel K Benjamin, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2003
A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solutionMelissa D Johnson, Carol D Hamilton, Richard H Drew, et al.
Journal of Clinical Microbiology|July 17, 2015
Challenges in Preparation of Cumulative Antibiogram Reports for Community HospitalsRebekah W Moehring, Kevin C Hazen, Myra R Hawkins, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Medical Mycology|March 4, 2011
Overview of treatment options for invasive fungal infectionsMelanie W Pound, Mary L Townsend, Vincent Dimondi, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 2017
Impact of automatic infectious diseases consultation on the management of fungemia at a large academic medical centerTravis M Jones, Richard H Drew, Dustin T Wilson, et al.
Infection Control and Hospital Epidemiology|March 16, 2012
Constructing unit-specific empiric treatment guidelines for catheter-related and primary bacteremia by determining the likelihood of inadequate therapyMegan E Davis, Deverick J Anderson, Michelle Sharpe, et al.
Clinical Therapeutics|May 31, 2015
Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor AgonistsStephanie L Payk, Richard H Drew, Jennifer D Smith, et al.
Cancer Medicine|March 20, 2014
Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort studyHsiang-Chi Kung, Melissa D Johnson, Richard H Drew, et al.
Expert Opinion on Pharmacotherapy|September 21, 2013
Recent advances in the treatment of life-threatening, invasive fungal infectionsRichard H Drew, Mary L Townsend, Melanie W Pound, et al.
Therapeutics and Clinical Risk Management|August 19, 2016
Role of isavuconazole in the treatment of invasive fungal infectionsDustin T Wilson, V Paul Dimondi, Steven W Johnson, et al.
Transplantation|January 27, 2004
Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipientsRichard H Drew, Elizabeth Dodds Ashley, Daniel K Benjamin, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2003
A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solutionMelissa D Johnson, Carol D Hamilton, Richard H Drew, et al.
Journal of Clinical Microbiology|July 17, 2015
Challenges in Preparation of Cumulative Antibiogram Reports for Community HospitalsRebekah W Moehring, Kevin C Hazen, Myra R Hawkins, et al.
Pageof 5